908 Devices Inc.

MASS

Precision medicineHealthcare diagnostics

$11.13vs prev close▲+0.45(+4.17%)

$5.0352W Range$10.70

100% from low

+3.54 (+49.58%)Past 1M

Price

ARK Trade PatternPREMIUM

1M Trades

No trades in 1M

1M net buy

≈ 0 shares

Portfolio Weight

0.13%

1M +0.01%p

Holding ETFs

1 ETFs

ARKG

Price Effect (Sell)

Shares decreased, but price appreciation increased portfolio weight.

Shares -0.6% · Market value -0.7% · Weight +0.01%p

Trade Intensity

No trades in 1M

Trade Log

Date	Action	ETF	Shares	Close	Est. total
25.08.13	SELL	ARKG	93,988	$7.05	$662.6K
25.08.12	SELL	ARKG	8,538	$6.47	$55.2K
25.08.11	SELL	ARKG	393	$6.43	$2.5K
25.08.07	SELL	ARKG	5,986	$6.42	$38.4K
25.08.06	SELL	ARKG	53,968	$6.53	$352.7K
25.08.04	SELL	ARKG	22,779	$6.52	$148.5K
25.08.01	SELL	ARKG	5,793	$6.42	$37.2K
25.07.31	SELL	ARKG	38,385	$6.55	$251.4K
25.07.08	SELL	ARKG	62,307	$6.81	$424.3K
25.07.07	SELL	ARKG	56,431	$6.41	$361.7K
25.07.03	SELL	ARKG	56,327	$6.65	$374.6K
25.07.02	SELL	ARKG	145,829	$6.61	$963.2K
25.07.01	SELL	ARKG	47,132	$6.48	$305.4K
24.09.13	SELL	ARKG	37,002	$3.60	$133.2K
24.09.12	SELL	ARKG	13,772	$3.47	$47.8K

08.13SELL

93,988

ARKGClose$7.05Est. total$662.6K

08.12SELL

8,538

ARKGClose$6.47Est. total$55.2K

08.11SELL

393

ARKGClose$6.43Est. total$2.5K

08.07SELL

5,986

ARKGClose$6.42Est. total$38.4K

08.06SELL

53,968

ARKGClose$6.53Est. total$352.7K

08.04SELL

22,779

ARKGClose$6.52Est. total$148.5K

08.01SELL

5,793

ARKGClose$6.42Est. total$37.2K

07.31SELL

38,385

ARKGClose$6.55Est. total$251.4K

07.08SELL

62,307

ARKGClose$6.81Est. total$424.3K

07.07SELL

56,431

ARKGClose$6.41Est. total$361.7K

07.03SELL

56,327

ARKGClose$6.65Est. total$374.6K

07.02SELL

145,829

ARKGClose$6.61Est. total$963.2K

07.01SELL

47,132

ARKGClose$6.48Est. total$305.4K

09.13SELL

37,002

ARKGClose$3.60Est. total$133.2K

09.12SELL

13,772

ARKGClose$3.47Est. total$47.8K

1 / 5

Prices estimated from market closing prices on trade dates. Actual execution prices may differ. This is not investment advice.

Stock Timeline

Institutional Holders

1 Holding · 0 Sold · Q4 2025

Based on ARK ETF real-time + 13F quarterly filings

Cathie WoodARK Invest

LIVE

1,900,610

Portfolio Weight

0.13%

in ETF 0.96%

Est. Value

$16M

30D Net

13F data may be delayed up to 90 days.

Market Context

Analyst Consensus

※ Analyst opinions are for reference only and do not constitute investment advice. Each securities firm may have different opinions.

Overall Opinion

Strong Buy

Buy

Analyst Targets

avg.

$13.00

vs Current ▲ +21.7% upside

Current$10.68

Low ~ High$12.00 ~ $14.00

Firm

Position

Price Target

Upside / Downside

Close Price

Action

Date

Stifel

Buy

$12.00

+12.36%

—

Maintain

2026-08-12

Roth Capital

Buy

$13.00

+21.72%

—

Maintain

2026-08-12

Roth Capital

Buy

$11.00

+3.00%

—

Upgrade

2026-07-29

Leerink Partners

Outperform

$12.00

+12.36%

—

Upgrade

2025-08-05

Stephens & Co.

Overweight

$6.00

-43.82%

—

Maintain

2025-01-15

1 / 4

Avg Target

$13.00

vs Current ▲ +21.7% upside

Strong Buy

5 analysts

Buy 5

Low $12.00

Current $10.68

High $14.00

Firm	Position	Target	Upside	Close	Action	Date
Stifel	Buy	$12.00	+12.36%	—	Maintain	26.08.12
Roth Capital	Buy	$13.00	+21.72%	—	Maintain	26.08.12
Roth Capital	Buy	$11.00	+3.00%	—	Upgrade	26.07.29
Leerink Partners	Outperform	$12.00	+12.36%	—	Upgrade	25.08.05
Stephens & Co.	Overweight	$6.00	-43.82%	—	Maintain	25.01.15

1 / 4

Price Information

Previous Close$10.35

Open$10.41

Day Range$10.15 - $10.69

52-Week Range$5.03 - $10.70

1-Year Change70.33%

Trading Volume

Volume528,311

Avg Volume (3mo)368,272

Valuation

Market Cap441.4M

Book Value$3.59

Shares Outstanding41,333,705

Financials

Revenue (TTM)60.8M

Net Income-34,381,000

EPS$-0.93

EBITDA-16,494,000

Profitability

P/E Ratio-

P/B Ratio2.98

Return on Equity (ROE)-24.95%

Return on Assets (ROA)-6.81%

Profit Margin-56.96%

EV/EBITDA-20.87

Beta0.63

Dividend

Dividend Rate-

Dividend Yield-

Technical

RSI(14)85.99

Company Overview

908 Devices Inc. is a commercial-stage technology company specializing in purpose-built handheld and desktop mass spectrometry devices. Their main products, like MX908, Rebel, and Maverick, are used for rapid analysis and real-time monitoring in life sciences, bioprocessing, and biopharma industries. The company offers innovative solutions for sample analysis and process control across various global markets.

P/B

2.98

Price-to-Book

ROE

-24.9%

Persistent loss

Beta

0.63

Market level

RSI(14)

86.0

Overbought

AI-generated summary. Not investment advice.

908 Devices Inc.

Analyst Consensus

Price Information

Trading Volume

Valuation

Financials

Profitability

Dividend

Technical

Related ARK stocks